Failure of morphogenesis in chronic inflammation-associated early tumourigenesis: Extracellular matrix biomechanics as an integrative layer Authors: Hirotaka Tao Published: 2026 ABSTRACT Chronic inflammation promotes tumourigenesis through both mutation accumulation and persistent failure of tissue repair mechanisms to restore organised three-dimensional architecture. However, current frameworks of inflammation-associated tumourigenesis often treat fibrosis, repair failure, immune dysfunction, and tissue disorganisation as parallel processes, without adequately explaining how they become mechanistically linked across biological scales or why repair can remain active while tissue-level order continues to deteriorate. We aimed to develop a conceptual framework that integrates these processes and clarifies how chronic inflammation acquires early tumourigenic potential. This review synthesised evidence from studies of chronic inflammation, extracellular matrix (ECM) biology, mechanobiology, tumour microenvironments, and developmental biology. The literature was analysed to identify common mechanisms linking repair failure, ECM remodelling, multicellular organisation, and precancerous tissue states. The review introduces the concept of failure of morphogenesis as a synthesis framework describing the persistent uncoupling of repair from tissue-level reorganisation. Within this framework, ECM biomechanics functions as a context-dependent integrative layer through which altered matrix mechanics propagate and stabilise precancerous disorder across five interconnected microenvironmental dimensions: mechanical change, immune restructuring, hypoxic amplification, mechanometabolic adaptation, and epigenetic persistence. Transferable physical principles from developmental biology further suggest mechanisms by which ECM-dependent disorder may become spatially organised and mechanically stabilised in chronically inflamed tissues. These findings suggest that precancerous lesions should be understood not only as mutation-bearing abnormalities but also as local manifestations of a broader self-reinforcing tissue condition. This review reframes the transition from chronic inflammation to cancer as extending beyond genetic damage alone to encompass tissue organisation. Introduction The tumour-associated ECM functions as a multilayered barrier surrounding developing cancer cells, creating multiple physical and biochemical obstacles that protect cancer cell proliferation from immune cell attacks. We recognise that tumours do not develop chaotically but rather according to specific principles. Therefore, a comprehensive understanding of the construction of the tumour-associated ECM within the inflammatory immune microenvironment, a hallmark of chronic inflammation, is critical [[1], [2], [3], [4], [5]]. The transition from chronic inflammation to cancer has conventionally been explained in genetic and molecular terms [[6], [7], [8], [9], [10]]. However, repeated injury can also impair the restoration of organised three-dimensional (3D) tissue architecture, leaving a persistent disordered state that favours tumourigenesis [1,[11], [12], [13], [14]]. This dynamic is particularly relevant to ulcerative colitis, where colorectal cancer risk increases progressively with disease duration [[15], [16], [17]] (Fig. 1A).Fig. 1Chronic inflammation-associated early tumourigenesis and the role of ECM remodelling in repair failure [1,3,[15], [16], [17], [18], [19], [20], [21], [22]]. (A) Overview of inflammation-associated colorectal tumourigenesis, highlighting chronic intestinal injury, microbiota-derived and inflammatory signals, regenerative activation, and progressive microenvironmental change. Together, these processes convert persistent mucosal damage into a broader pro-tumourigenic field shaped by impaired immunosurveillance, stromal activation, and ECM remodelling. (B) Dynamic ECM homeostasis and its disruption during chronic inflammation. Under physiological conditions, ECM deposition, degradation, crosslinking, and force transmission remain balanced to support tissue repair. Chronic disruption stabilises abnormal stiffness, matrix disorganisation, and persistent signalling, thereby contributing to failure of morphogenesis. Chronic inflammation-associated early tumourigenesis and the role of ECM remodelling in repair failure [1,3,[15], [16], [17], [18], [19], [20], [21], [22]]. (A) Overview of inflammation-associated colorectal tumourigenesis, highlighting chronic intestinal injury, microbiota-derived and inflammatory signals, regenerative activation, and progressive microenvironmental change. Together, these processes convert persistent mucosal damage into a broader pro-tumourigenic field shaped by impaired immunosurveillance, stromal activation, and ECM remodelling. (B) Dynamic ECM homeostasis and its disruption during chronic inflammation. Under physiological conditions, ECM deposition, degradation, crosslinking, and force transmission remain balanced to support tissue repair. Chronic disruption stabilises abnormal stiffness, matrix disorganisation, and persistent signalling, thereby contributing to failure of morphogenesis. However, existing conceptual frameworks of inflammation-associated tumourigenesis continue to describe repair failure, fibrosis, immune dysfunction, field change, and tissue disorganisation as parallel features rather than as mechanistically coupled components of a single tissue-level process [1,3,7,11,13,[18], [19], [20]]. Consequently, this framing does not fully explain why repair can remain chronically active while tissue-level order continues to deteriorate, or how epithelial, stromal, immune, and matrix abnormalities become durably coupled across biological scales. Therefore, to address this gap, the present review introduces the concept of ‘failure of morphogenesis’ to name this specific unresolved condition: the persistent uncoupling of repair from tissue-level reorganisation. This framework is not proposed as a new lesion category, but rather as a synthesis framework for understanding early tumourigenesis as the stabilisation of disordered tissue architecture under conditions of unresolved repair. Within this framework, extracellular matrix (ECM) biomechanics serves as an integrative layer, as stiffness, viscoelasticity, topology, and composition help determine how epithelial, stromal, and immune cells respond to damage and remodel their environment [3,[23], [24], [25], [26], [27], [28], [29], [30]] (Fig. 1B). Therefore, these properties help explain how chronic inflammation acquires early tumourigenic potential. The failure of morphogenesis framework identifies the specific condition in which mechanisms that normally re-establish tissue order following injury remain active but fail to restore multicellular organisation, allowing spatial disorder to become biologically stable. While this framework is compatible with established concepts, such as fibrosis, aberrant wound healing, and field cancerisation, it is distinguished by its explicit focus on the persistent loss of tissue-level order across epithelial, stromal, immune, and matrix compartments (Fig. 2A). As mentioned previously, within this framework, ECM biomechanics serves as an integrative axis through which five experimentally grounded microenvironmental dimensions—mechanical change, immune restructuring, hypoxic amplification, mechanometabolic adaptation, and epigenetic persistence—become reciprocally coupled across these compartments (Fig. 2C). It differs from other concepts in that early tumourigenesis refers to the process by which chronically inflamed tissues become permissive for neoplastic transformation, a precancerous lesion refers to the local pathological expression of this process, and a pro-tumourigenic field or state indicates the broader tissue condition in which it unfolds.Fig. 2ECM biomechanics as an integrative layer across inflammatory microenvironmental domains [[1], [2], [3], [4], [5],[23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35]]. (A) Cross-scale coupling in morphogenetic failure, illustrating how altered matrix mechanics may link epithelial, stromal, immune, and matrix compartments within a persistent precancerous state. (B) Major modes of ECM remodelling in early tumourigenesis, including proteolytic degradation, post-translational modification, altered deposition and composition, and force-mediated physical remodelling. (C) Propagation of ECM-dependent disorder across five experimentally grounded microenvironmental layers: mechanical change, immune restructuring, hypoxic amplification, mechanometabolic adaptation, and epigenetic persistence. ECM biomechanics as an integrative layer across inflammatory microenvironmental domains [[1], [2], [3], [4], [5],[23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35]]. (A) Cross-scale coupling in morphogenetic failure, illustrating how altered matrix mechanics may link epithelial, stromal, immune, and matrix compartments within a persistent precancerous state. (B) Major modes of ECM remodelling in early tumourigenesis, including proteolytic degradation, post-translational modification, altered deposition and composition, and force-mediated physical remodelling. (C) Propagation of ECM-dependent disorder across five experimentally grounded microenvironmental layers: mechanical change, immune restructuring, hypoxic amplification, mechanometabolic adaptation, and epigenetic persistence. Therefore, the present review follows a focused conceptual progression: Section 2 defines failure of morphogenesis as the tissue-level condition that enables precancerous lesion formation; Section 3 establishes ECM biomechanics as the principal integrative layer through which this condition acquires pro-tumourigenic properties, coupling epithelial plasticity, stromal remodelling, immune dysfunction, hypoxic adaptation, metabolic rewiring, and epigenetic persistence; and Section 4 introduces transferable physical principles from developmental biology to clarify how multicellular disorders become spatially organised and stabilised, without extending the conceptual scope of the review. Together, these sections support the central claim that precancerous lesions should be understood not simply as mutation-bearing abnormalities, but as local manifestations of a mechanically and biologically self-reinforcing disorder tissue state. The present framework is further supported by recent research [6,14,17,21,36,37]. Reviews published in 2025–2026 increasingly describe ECM in inflammation and cancer as a dynamic and potentially disease-organising system rather than a passive stromal residue [[31], [32], [33], [34], [35],37]. These reviews further refine how persistent mucosal injury, immune plasticity, and stromal remodelling cooperate in colitis-associated colorectal tumourigenesis [17,[38], [39], [40]]. Moreover, spatial omics is shifting from descriptive atlas-building towards the identification of functional neighbourhoods and clinically relevant tissue states [[41], [42], [43], [44], [45]]. Together, these advances render the central question more experimentally tractable, shifting focus from whether chronic inflammation promotes cancer to how ECM-dependent tissue disorder becomes spatially stabilised, immunologically reinforced, and measurable in situ [44,[46], [47], [48], [49], [50]]. Chronic inflammation as a failure of morphogenesis This section defines chronic inflammation-associated early tumourigenesis as a failure of morphogenesis: a condition in which repair no longer restores organised 3D architecture but instead stabilises a viable yet disordered tissue state. The term is necessary because the problem addressed in the present review is not adequately captured by existing descriptions of chronic inflammation as merely persistent signalling, fibrosis, or aberrant wound healing. Although these concepts identify important components of the process, they fail to sufficiently explain why repair can remain active while tissue-level order continues to deteriorate, or how epithelial, stromal, immune, and matrix abnormalities become durably coupled across biological scales. In the adult inflammatory context, morphogenesis refers not to embryonic pattern formation but to the ongoing tissue-level process by which injury responses re-establish spatial organisation, compartmental relationships, and functional multicellular order during repair. Therefore, failure of morphogenesis denotes the persistent uncoupling of these repair programmes from tissue-level reorganisation. This term is used to indicate a synthesis framework rather than a new lesion category, linking failed repair, ECM remodelling, multicellular reciprocity, and spatially persistent disorder across epithelial, stromal, immune, and matrix compartments. This framework does not equate chronic inflammation with embryogenesis or diminish the importance of mutation. Instead, it clarifies why a distinct concept is needed if early tumourigenesis is to be understood as both molecular damage accumulation and the stabilisation of disordered tissue architecture under conditions of unresolved repair. The following section outlines the contributions of disrupted ECM homeostasis, regenerative pressure, inflammatory signalling, and microbiota-associated stress to this state. As mentioned previously, this framework differs from several established concepts while remaining compatible with them. For example, tissue remodelling describes structural change but not whether that change restores or destabilises higher-order tissue architecture. While field cancerisation [1,11,19] captures the spatial extension of altered cancer risk, it does not explain how multicellular disorder becomes organised and sustained. Moreover, aberrant wound healing emphasises defective repair responses [12,22,51], whereas the present term focuses more specifically on the failure to recover tissue-level order across the four compartments. Fibrosis refers to excessive ECM accumulation and altered matrix turnover [3,20,22,31,52,53]; however, fibrosis alone is not equivalent to a pro-tumourigenic state. Similarly, tumour-promoting inflammation describes an inflammatory milieu favourable to neoplasia without specifying the mechanisms by which tissue architecture becomes durably reorganised [[6], [7], [8], [9], [10],54]. Therefore, the analytical necessity of failure of morphogenesis lies in naming the specific condition that these adjacent concepts collectively leave partially resolved: persistent repair activity without restoration of multicellular order. In this review, this term is used as an integrative cross-scale concept for the condition in which repair failure, ECM remodelling, regenerative pressure, immune dysfunction, and spatial disorder remain persistently coupled. The ECM comprises structural and signalling molecules that maintain tissue architecture and mechanical homeostasis [3,19,23,28,30,55]. Under physiological conditions, ECM deposition, degradation, crosslinking, and force transmission remain balanced [[22], [23], [24], [25], [26],28,30]. However, during chronic inflammation, these same systems can stabilise abnormal stiffness, altered architecture, and persistent inflammatory signalling [3,22,31,32,35,53]. This shift helps explain why fibrosis and ECM remodelling are recurrent features of early tumourigenic tissues [3,13,18,21,52]. Clinically, this process is exemplified by inflammatory bowel disease [[15], [16], [17],56]. Persistent barrier injury imposes repeated regenerative demand on tissues that are already mechanically and immunologically altered. Programmes that are initially adaptive, including stem-cell expansion, epithelial plasticity, and inflammatory cell turnover, may subsequently become chronically activated, promoting cell-state instability and prolonged inflammatory signalling [[57], [58], [59], [60], [61]]. Consequently, repair shifts from a resolving response to a persistent source of regenerative pressure. Microbial dysbiosis further reinforces the persistence of this state [[62], [63], [64], [65]]. In particular, increased permeability, endotoxaemia, cytokine release, and altered ECM turnover reinforce one another, and intracellular defects in collagen handling may further promote fibrotic accumulation [31,[66], [67], [68], [69], [70]]. Together, dysbiosis, inflammatory signalling, altered metabolism, and impaired matrix turnover converge on a chronically remodelled tissue environment in which ECM abnormalities are continuously produced, sensed, and reinforced. Collectively, these observations support the use of failure of morphogenesis as a framework for chronic inflammation when repair, ECM remodelling, inflammatory signalling, and regenerative activation remain persistently coupled. ECM biomechanics as an integrative layer in morphogenetic failure If failure of morphogenesis defines the tissue-level condition in which chronic inflammation ceases to restore order, the next question is how that condition becomes mechanistically integrated and biologically durable. Therefore, this section examines how ECM biomechanics may link repair failure to immune dysfunction, hypoxic adaptation, metabolic rewiring, and epigenetic persistence across the evolving precancerous microenvironment. It also explores how these processes propagate across immune, hypoxic, metabolic, and epigenetic layers of the inflammatory microenvironment. Mechanical microenvironment In early tumourigenesis, ECM remodelling can be categorised into four major processes: proteolytic degradation, post-translational modification, altered deposition and composition, and force-mediated physical reorganisation [3,30,31,52] (Fig. 2B). Together, these changes influence stiffness, architecture, and bioactive signal release, shaping the earliest mechanical conditions of the precancerous niche. Recent evidence suggests that these changes can exert pro-tumourigenic effects early in disease progression, rather than being restricted to established tumours [1,3,14,18,21,32]. Stiffness and viscoelasticity influence mechanosensitive regulators, such as YAP/TAZ, and may reorganise cell behaviour before overt malignancy [24,29,32,[71], [72], [73]]. In 3D tissues, stiffness alone is insufficient to explain this behaviour, as viscoelastic relaxation, matrix topology, and force dissipation also determine how cells sense mechanical load, remodel their surroundings, and maintain traction over time [25,26,29,74,75]. Therefore, the mechanical microenvironment should be viewed not as an isolated niche property but as a principal route through which matrix abnormalities begin to reshape immunity, oxygen adaptation, metabolism, and chromatin state. This view of the early mechanical niche is supported by experimental evidence [24,25,27,29,32,76]. In 3D matrix systems, controlled variation of matrix stiffness and stress relaxation can alter cell spreading, traction maintenance, and YAP/TAZ-associated mechanosignalling, indicating that mechanically similar matrices promote different cell behaviours when viscoelastic dissipation differs [24,26,29,[71], [72], [73],76]. Complementary studies of integrin-based adhesions further demonstrate that force transmission through talin-, vinculin-, and focal-adhesion–linked complexes is dynamically regulated by matrix load and architecture rather than by stiffness alone [24,70,[76], [77], [78]]. Collectively, these observations support the notion that early ECM remodelling can generate biologically distinct precancerous conditions through the combined effects of stiffness, viscoelasticity, and force propagation [24,26,29,32,34,75]. Immune microenvironment Within the immune microenvironment, ECM remodelling influences immune cell recruitment, positioning, activation, and persistence [1,2,4,11,[79], [80], [81]]. Matrix composition, proteolysis, stiffness, and ligand presentation collectively shape the states of macrophages and lymphocytes. Moreover, matrix metalloproteinase (MMP)-dependent ECM cleavage generates chemotactic and immunomodulatory fragments that further modulate the local immune milieu [31,35,[82], [83], [84]]. Therefore, immune dysfunction does not merely arise downstream of matrix change but represents a primary route by which mechanical disturbance becomes biologically durable. In this context, tumour-associated ECM can function as a multilayered physical and biochemical barrier that limits immune cell access and weakens effective antitumour responses around emerging cancer cells. Consequently, instead of a chaotic process, tumour development should be viewed as a process that becomes progressively structured through interactions among matrix remodelling, inflammatory signalling, and immune organisation. This highlights the importance of comprehensively understanding how tumour-associated ECM is established within the inflammatory immune microenvironment, which is a hallmark of chronic inflammation. Immune cells navigate, remodel, and sense the ECM through proteases, integrins, and mechanosensitive channels [2,31,74,[79], [80], [81],85]. These interactions determine the spatial distribution of immune cell accumulation and their functional states within inflamed tissues. Structural remodelling and bioactive ECM fragments are thus active participants in immune regulation, not passive background features [2,31,81,83,84,86]. Consistent with this, increasing evidence indicates that ECM changes directly reprogramme immune behaviour. Mechanobiology studies indicate that immune cells respond to tissue stiffness and force transmission through dedicated mechanotransduction pathways, altering activation thresholds, migration, and effector function [24,32,76,80,85,87]. Experimental tumour models and matrix-focused analyses indicate that ECM organisation can limit immune cell infiltration and help establish immunoregulatory macrophage phenotypes, whereas MMP-dependent matrix cleavage releases fragments with direct immunomodulatory activity [1,4,5,31,[82], [83], [84],88]. These data support the idea that matrix disturbance does not merely accompany immune dysfunction but can actively structure it in ways that stabilise inflammatory tissue disorder [2,4,11,35,79]. Overall, immune remodelling is one of the first routes by which matrix disturbance becomes durable tissue dysfunction. Once ECM change redirects immune cell recruitment, retention, and activation, it also reshapes oxygen availability and stress adaptation, directly linking immunity to the next hypoxic layer. Hypoxic microenvironment Hypoxia is a major field-level factor that redistributes and prolongs ECM-dependent disorder across the lesion [[89], [90], [91], [92], [93]]. Fibrosis, accumulation of immune cells, and vascular dysfunction progress in concert; therefore, oxygen limitation activates HIF-, NF-κB-, and STAT-dependent programmes that couple matrix remodelling, epithelial adaptation, and immune dysfunction [[90], [91], [92], [93], [94], [95], [96]]. Therefore, hypoxia is not an independent stressor; it is a mechanism by which altered tissue organisation is redistributed and prolonged across the lesion. This coupling is supported by mechanistic studies demonstrating that oxygen limitation promotes collagen crosslinking, proteolytic remodelling, immune suppression, and stress tolerance through LOX-family enzymes, HIF-regulated proteases, and context-dependent fibroblast responses [92,[96], [97], [98], [99], [100], [101]]. However, these effects are variable and depend on timing, cell type, and tissue context [87,88,93,99]. Classical and contemporary studies demonstrate that hypoxic regions emerge where tissue organisation and perfusion become limiting, and that HIF activation induces collagen-crosslinking enzymes, proteases, and epithelial programmes that reinforce matrix remodelling and stress adaptation [71,92,93,[96], [97], [98], [99], [100]]. More recent analyses further indicate that oxygen tension reshapes immune behaviour and inflammatory signalling, helping convert local oxygen limitation into a broader field condition rather than a purely cell-autonomous response [[92], [93], [94], [95],101,102]. Collectively, these findings suggest that hypoxia functions as an amplifier that redistributes ECM-dependent disturbance across multicellular tissue compartments. Overall, hypoxia is best viewed as a field-level amplifier of ECM-dependent disorder, rather than an isolated stressor. By influencing collagen crosslinking, proteolytic activity, immune suppression, and stress adaptation, it helps redistribute mechanical disturbance across the lesion and link matrix change to metabolic and epigenetic persistence. Metabolic microenvironment Metabolism is a main route through which ECM-dependent disorder becomes biologically durable [[103], [104], [105], [106], [107], [108]]. Altered ECM physical properties, including stiffness, viscoelastic relaxation, architecture, and force transmission, reshape how cells sense load through integrins, focal adhesions, cortical tension, and cytoskeletal organisation. These mechanical inputs then converge on mechanotransduction pathways, such as FAK/SRC, Rho-associated tension signalling, YAP/TAZ, PI3K/AKT/mTOR, and AMPK, coupling mechanical demand to energy sensing and biosynthetic regulation [24,[71], [72], [73],78,103,[109], [110], [111], [112]]. Downstream, these pathways reshape glucose utilisation, lipid handling, amino acid metabolism, mitochondrial organisation, and redox balance [[106], [107], [108],110,[113], [114], [115], [116], [117]]. The resulting metabolic rewiring supports altered nutrient uptake, stress adaptation, stromal metabolic support, and the persistence of mechanically stressed cell states. Therefore, this metabolic rewiring should not be viewed as a secondary by-product of matrix remodelling but as a mechanism by which the mechanically altered precancerous state becomes energetically viable and self-sustaining. Recent work in mechanometabolism supports this mechanical disruption sequence at several levels [[103], [104], [105], [106], [107],109,116]. In cell and tissue models, matrix stiffness and related mechanical cues can increase glucose uptake, alter glycolytic dependence, reorganise mitochondrial dynamics, modulate lipid and amino acid metabolism, and regulate stromal–tumour metabolic exchange through YAP/TAZ-, PI3K/AKT/mTOR-, and AMPK-linked programmes [73,98,103,105,[107], [108], [109],116]. Adhesion-associated mechanotransduction through integrin-linked complexes and FAK/vinculin/talin-dependent force transmission provides a physical route through which matrix load is relayed to YAP/TAZ activity and downstream metabolic programmes [24,73,[76], [77], [78],109]. Moreover, recent research on mechanometabolism further suggests that migration, adhesion, and metabolic state are reciprocally coupled rather than linearly ordered [74,103,104,109], supporting the view that altered matrix conditions may help stabilise energetically viable but abnormal cell states. Although these findings do not suggest that ECM mechanics uniquely determines metabolic state, they indicate that altered matrix conditions can channel mechanotransduction into coordinated metabolic adaptation across the epithelial, stromal, and immune compartments of the lesion. This supports the view that ECM-dependent metabolic rewiring is a mechanism by which chronically inflamed tissue maintains energetic viability in a persistently disordered state [103,105,106,118,119]. Therefore, the significance of ECM-dependent metabolic rewiring extends beyond intracellular pathway changes to the maintenance of a multicellular tissue state that remains energetically viable under chronic inflammatory stress. However, matrix stiffness alone is insufficient to explain metabolic behaviour in 3D tissues. In 3D settings, viscoelasticity, matrix topology, degradability, and force dissipation also influence how cells maintain traction, adapt to confinement, and allocate energy under sustained load. Therefore, in this review, the analytical value of mechanometabolism as a framework lies not in reducing metabolism to matrix stiffness, but in revealing how multiple ECM physical properties can organise metabolic adaptation across mechanically heterogeneous lesions. The unresolved question remains which mechanically coupled metabolic features merely accompany chronic inflammation and which actively stabilise a self-reinforcing pro-tumourigenic precancerous state. Epigenetic microenvironment Epigenetic regulation is a mechanism by which the mechanically altered precancerous state becomes transcriptionally durable [[119], [120], [121], [122], [123], [124], [125]]. Inflammatory signalling, DNA damage, force transmission, and metabolic imbalance converge on chromatin organisation, DNA accessibility, and non-coding RNA networks [8,10,112,[119], [120], [121],[126], [127], [128], [129]]. Therefore, the epigenetic microenvironment is not a terminal downstream effect, but rather a persistence layer within morphogenetic failure. Taken together, these data indicate that immune remodelling, hypoxic adaptation, metabolic rewiring, and epigenetic persistence are not parallel consequences of chronic inflammation but reciprocally coupled processes. Altered matrix mechanics provide a material context in which these processes become progressively self-reinforcing across the precancerous microenvironment. An important unresolved question is how ECM-dependent disorder becomes spatially organised and mechanically stabilised, thereby transitioning from persistence to a structurally sustained tissue state. Developmental biology as a source of transferable physical principles This section draws on developmental biology in a limited conceptual sense, exploring transferable physical principles that may help explain how an ECM-dependent disorder becomes spatially organised and mechanically stabilised. To address this question, developmental biology is viewed not as a direct analogue of precancer but as a limited source of general physical principles that may inform the organisation of chronically inflamed tissues. The purpose of these examples is analytical rather than illustrative: to identify general physical constraints, delineate where their relevance to chronic inflammation is strongest, and highlight key areas of uncertainty, rather than classify developmental analogies. Therefore, this section aims to clarify how morphogenetic failure may acquire stable spatial patterns, directional tissue rearrangement, and early invasive capacity across chronically inflamed tissues. Three principles are considered: anisotropic growth, stiffness-guided migration and phase transition, and energetically constrained invasive state transition (Fig. 3) [[131], [132], [133], [134], [135],142,143,[146], [147], [148], [149], [150]]. Together, these principles provide a physical vocabulary for interpreting how chronically inflamed tissues acquire and maintain pro-tumourigenic architecture before overt malignancy.Fig. 3Transferable physical principles from morphogenesis for analysing chronic inflammation and early tumourigenesis [[129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145]]. (A) Ectodermal cell intercalation during limb bud initiation as an example of anisotropic growth coupled to force redistribution. (B) Cortical force oscillations during mandibular arch development. (C) Region-specific control of mitotic integrity and chromatid segregation during limb bud shaping. (D) Stiffness-guided migration and jamming–unjamming transitions as principles of collective tissue reorganisation. (E) Neural crest ingression as a model of invasive state transition constrained by adhesion, mechanics, and energetic state. Transferable physical principles from morphogenesis for analysing chronic inflammation and early tumourigenesis [[129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145]]. (A) Ectodermal cell intercalation during limb bud initiation as an example of anisotropic growth coupled to force redistribution. (B) Cortical force oscillations during mandibular arch development. (C) Region-specific control of mitotic integrity and chromatid segregation during limb bud shaping. (D) Stiffness-guided migration and jamming–unjamming transitions as principles of collective tissue reorganisation. (E) Neural crest ingression as a model of invasive state transition constrained by adhesion, mechanics, and energetic state. Anisotropic growth as a principle of spatial tissue remodelling The first principle helps clarify how precancerous architecture may become spatially biased and mechanically stabilised before overt malignancy. Tissue form depends on the extent of tissue growth, the spatial distribution of growth heterogeneity, and how that asymmetry is coupled to surrounding matrix and tissue constraints [[133], [134], [135], [136], [137], [138],[146], [147], [148],151,152]. In chronic inflammation, this principle suggests that regenerative growth and ECM remodelling may fail to restore order and instead stabilise anisotropic deformation, thereby helping to convert persistent injury into pro-tumourigenic architecture. Developmental and tumour studies converge on a broader insight: tissue architecture is shaped by proliferation and redistribution of uneven forces through adhesion, force transmission, and matrix constraint [133,136,144,[152], [153], [154]]. These data reframe the central question in chronic inflammation: not whether regenerative expansion occurs, but whether growth becomes durably channelled into spatially biased, mechanically constrained configurations that no longer resolve toward organised tissue form. In chronic inflammation and precancer, this implies that early pro-tumourigenic architecture may emerge when regenerative growth, ECM remodelling, and local stress cease to restore order and instead stabilise structural disequilibrium. However, a critical qualification remains: anisotropic growth alone is insufficient to suggest precancerous progression, as similar asymmetries arise in adaptive repair or regeneration. Therefore, its analytical value lies specifically in defining when spatially biased growth remains transient and self-resolving, and when it becomes persistently coupled to ECM remodelling and architectural disequilibrium. Overall, in this review, the value of the developmental comparison is narrowly conceptual, as it clarifies how persistent injury can be converted into spatially biased, mechanically maintained precancerous organisation rather than merely increased proliferation. Stiffness-guided migration and phase transition as principles of tissue reorganisation The second principle helps clarify how ECM-dependent heterogeneity may pre-pattern cell positioning, confinement, and rearrangement before invasion becomes histologically evident. Tissue reorganisation depends on where stiffness gradients bias cell movement and where collective behaviour undergoes phase change [131,[139], [140], [141], [142], [143],149,155,156]. In chronic inflammatory tissues, these processes suggest a mechanism by which mechanically heterogeneous lesions become spatially organised for invasive plasticity, reinforcing a pro-tumourigenic state before overt malignant transition. Research on durotaxis, jamming–unjamming, and ECM degradation suggests a common analytical principle: tissue reorganisation depends both on stiffness and how cells interpret, amplify, and collectively respond to mechanical heterogeneity [141,145,149,[157], [158], [159]]. The value of this comparison for precancer is therefore specific, as it suggests a way to distinguish simple matrix irregularity from a consequential state in which heterogeneity begins to pre-pattern confinement, rearrangement, and invasive plasticity across an inflamed lesion. In this limited developmental analogy, ECM-dependent heterogeneity is interpreted as a mechanism that can organise invasive plasticity in advance and thereby contribute to the spatial stabilisation of a pro-tumourigenic precancerous state. Notably, the relevance of durotaxis, jamming, or unjamming to inflammation-associated precancer is unlikely to be uniform across tissues. Therefore, in this review, these concepts do not serve as universal explanations, but rather as comparative tools for distinguishing when ECM heterogeneity remains compatible with repair and when it instead begins to organise persistent invasive plasticity. Thermal energy and cell ingression as principles of invasive state transition The third principle clarifies how mechanically disordered tissues may begin to stabilise invasive potential before overt carcinoma emerges. Invasive state transitions depend on how energetic state, adhesion, and mechanical context constrain the routes by which cells disengage from organised tissues [74,109,140,145,150,160]. In chronic inflammation, this suggests that hypoxia, matrix remodelling, and metabolic stress may favour lower-cost migratory states that preserve disorder rather than restore tissue architecture, thereby linking tissue-level instability to early pro-tumourigenic behaviour. Studies of migration plasticity support a broader comparative principle: invasive behaviour is shaped both by genotype and whether energetic and mechanical constraints favour lower-cost routes out of organised tissue [74,109,150,159,160]. In chronic inflammation, these studies are important as they suggest that hypoxia, matrix remodelling, and metabolic stress may progressively select for cell states that preserve disorder rather than restore tissue architecture, instead of implying that these transitions are already malignant. The broader implication is that, within a mechanically altered tissue environment, invasive potential may be shaped by genetic changes and energetic constraints. Importantly, energetic constraint is not unique to precancer; related adaptive transitions also occur in wound healing, immune cell trafficking, and transient tissue remodelling [12,51,81,140,161,162]. Therefore, the central issue is not whether migratory plasticity is present, but whether lower-cost invasive states become stabilised within a mechanically altered and unresolved inflammatory environment. Taken together, these transferable principles are introduced in the present review to clarify how ECM-dependent morphogenetic failure may become spatially patterned, mechanically stabilised, and progressively permissive for early tumourigenesis before overt carcinoma emerges. Instead of establishing direct equivalence between development and precancer, these principles highlight the following questions: which physical features are generic to tissue remodelling, which are more specific to unresolved inflammatory disorder, and which are most likely to predict progression. Therefore, they do not establish developmental biology as an explanatory substitute for precancer. Limitations and future perspectives The value of the present framework depends on whether it can distinguish a reversible inflammatory lesion from a self-reinforcing pro-tumourigenic precancerous state. Therefore, this section considers the limitations of this framework in explicitly testable terms. ECM biomechanics may not be the dominant organising force in all tissues, and fibrosis is not synonymous with a pro-tumourigenic state. Therefore, the framework is best understood as a context-dependent model whose usefulness depends on identifying which spatial, mechanical, and multicellular features persist, couple, and predict progression in inflammation-associated epithelial cancers, particularly in the intestine. Testable predictions of the framework If this framework is to distinguish a reversible inflammatory lesion from a self-reinforcing pro-tumourigenic precancerous state, it must generate falsifiable predictions rather than redescribe disorder. Lesions with similar inflammatory burden or mutation load should differ in tumourigenic potential according to whether ECM remodelling becomes spatially stabilised alongside architectural disorder, immune dysregulation, and altered stress adaptation. Similarly, perturbations that restore mechanical homeostasis or reduce matrix crosslinking should weaken some features of the disordered precancerous state even if inflammation is not fully resolved. These predictions can be linked explicitly to the experimentally grounded layers outlined in Section 3. First, if the mechanical microenvironment is an early integrative layer, lesions with comparable inflammatory burden should still differ according to whether altered stiffness, viscoelastic relaxation, and force transmission are accompanied by persistent YAP/TAZ-associated mechanosignalling and spatially biased tissue deformation [24,26,29,34,71,72]. Second, if immune dysfunction is partly matrix-structured, lesions with similar immune cell abundance should differ according to whether ECM organisation limits immune cell penetration, supports immunoregulatory macrophage states, or generates immunomodulatory matrix fragments [1,2,4,82,83,88]. Notably, the present framework predicts whether the stable coupling of these features renders a lesion more likely to persist as a pro-tumourigenic state, rather than sampling predicting their presence. Third, if hypoxia acts as a field-level amplifier, mechanically disordered lesions should exhibit spatial coupling between perfusion constraints, HIF-linked matrix remodelling programmes, and altered immune behaviour across neighbouring compartments [[89], [90], [91],94,101]. Fourth, if mechanometabolic adaptation helps sustain disorder, lesions with similar histology should differ according to whether altered matrix load is accompanied by coordinated changes in glucose uptake, ATP dynamics, mitochondrial organisation, and AMPK/mTOR-linked energy sensing [[103], [104], [105],109,116,163]. Fifth, if epigenetic persistence is integral to this process, mechanically perturbed lesions should display more durable changes in nuclear shape, chromatin accessibility, and force-sensitive transcriptional programmes than lesions in which remodelling remains transient [[123], [124], [125], [126]]. Collectively, these linked predictions experimentally strengthen the framework by specifying measurement targets and defining the coupled spatial-mechanical features that distinguish reversible inflammatory remodelling from self-reinforcing precancerous organisation. Current model systems capture important but partial aspects of chronic inflammation-associated early tumourigenesis. As the process likely emerges from reciprocal interactions among ECM mechanics, inflammatory signalling, hypoxia, metabolism, and cell-state plasticity, the most informative platforms will be those that preserve spatial architecture, dynamic material properties, and multicellular reciprocity. For example, spatial multimodal profiling, live imaging of ECM and ATP dynamics, tissue-scale stiffness mapping, and computational modelling enable the exploration of inflammatory, metabolic, and chromatin states in relation to ECM mechanics in vivo. Together, these experimental and analytical directions define practical routes for testing morphogenetic failure in inflammation-associated tumourigenesis (Fig. 4). Notably, spatial technologies are increasingly being framed as both discovery tools and candidates for clinically relevant assays [41], [44], [46], [47], [49], [50], [[163], [164], [165], [166], [167], [168]].Fig. 4Experimental and analytical directions for testing morphogenetic failure in inflammation-associated tumourigenesis [[41], [42], [43], [44], [45], [46], [47], [48], [49], [50],164,165]. (A) Field-level view of precancerous change, showing that local lesions arise within a broader unresolved tissue condition. (B) Experimental platforms for testing the framework across coupled microenvironmental layers, including engineered in vitro systems, organoid and microphysiological models, spatial multimodal profiling, live imaging, in vivo biomechanical measurement, and computational modelling. (C) Chemical and mechanical pattern-forming parameters relevant to tissue organisation. (D) Integrated testable predictions of the framework, illustrating that lesions with similar inflammatory burden or histology may still differ in progression risk according to whether mechanical, immune, hypoxic, metabolic, and epigenetic features remain spatially and temporally coupled. Experimental and analytical directions for testing morphogenetic failure in inflammation-associated tumourigenesis [[41], [42], [43], [44], [45], [46], [47], [48], [49], [50],164,165]. (A) Field-level view of precancerous change, showing that local lesions arise within a broader unresolved tissue condition. (B) Experimental platforms for testing the framework across coupled microenvironmental layers, including engineered in vitro systems, organoid and microphysiological models, spatial multimodal profiling, live imaging, in vivo biomechanical measurement, and computational modelling. (C) Chemical and mechanical pattern-forming parameters relevant to tissue organisation. (D) Integrated testable predictions of the framework, illustrating that lesions with similar inflammatory burden or histology may still differ in progression risk according to whether mechanical, immune, hypoxic, metabolic, and epigenetic features remain spatially and temporally coupled. Overall, future progress will depend on integrating developmental biology, physics, mechanobiology, spatial technologies, and multiscale model systems. The central challenges are to render morphogenetic failure experimentally measurable as a tissue process and determine measurable spatial, mechanical, and multicellular features that reliably identify the transition from reversible inflammatory disorder to a self-reinforcing pro-tumourigenic precancerous state. Concluding remarks The present review contends that early tumourigenesis in chronic inflammation is not adequately explained by mutation accumulation, fibrosis, or aberrant repair considered in isolation. Specifically, the persistent condition in which repair remains active but no longer restores organised three-dimensional tissue architecture requires clarification. To address this unresolved problem, failure of morphogenesis is introduced as a necessary synthesis framework for understanding how chronic inflammation can stabilise a viable yet disordered tissue state. Within this framework, ECM biomechanics is not proposed as a universal first cause, but as a context-dependent integrative layer through which repair failure becomes spatially patterned, mechanically stabilised, and biologically persistent across epithelial, stromal, immune, and matrix compartments. The central implication is that precancerous progression is most likely to emerge when mechanical change, immune restructuring, hypoxic amplification, mechanometabolic adaptation, and epigenetic persistence become reciprocally coupled into a self-reinforcing tissue state, rather than when these layers merely coexist. Therefore, beyond describing chronic inflammatory disorder, the value of this framework lies in identifying the spatial, mechanical, and multicellular features that distinguish a reversible lesion from a self-reinforcing pro-tumourigenic precancerous state, and in rendering this distinction experimentally tractable. Framed in this way, the transition from chronic inflammation to cancer should be understood as extending beyond genetic damage to include tissue organisation. This shift in perspective represents the central claim of this review and underlies the use of failure of morphogenesis as a distinct conceptual tool. Declaration of generative AI and AI-assisted technologies in the manuscript preparation process During the preparation of this work, the author used Copilot to refine the language and enhance the clarity of the manuscript. After using this tool, the author reviewed and edited the content as necessary and takes full responsibility for the content of the published article. Funding This work was supported by KAKENHI Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant Numbers 20K22657 and 21H03003) and by UBE Corporation (Award Number 214240AE02). The funders had no role in the design of the study; the collection, analysis, or interpretation of data; the writing of the manuscript; or the decision to publish the results. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.